Impact Factor 5.511
2017 JCR, Clarivate Analytics 2018

Among the world's top 10 most-cited Immunology journals

Mini Review ARTICLE Provisionally accepted The full-text will be published soon. Notify me

Front. Immunol. | doi: 10.3389/fimmu.2019.01222

What makes a pDC: recent advances in understanding plasmacytoid DC development and heterogeneity

  • 1Institute for Immunology, Biomedical Center, Ludwig Maximilian University of Munich, Germany

Dendritic cells (DCs) are professional antigen presenting cells (APCs) that originate in the bone marrow and are continuously replenished from hematopoietic progenitor cells. Conventional DCs (cDCs) and plasmacytoid DCs (pDCs) are distinguished by morphology and function, and can be easily discriminated by surface marker expression both in mouse and man. Classification of DCs based on their ontology takes into account their origin as well as their requirements for transcription factor (TF) expression. cDCs and pDCs of myeloid origin differentiate from a common DC progenitor (CDP) through committed pre-DC stages. pDCs have also been shown to originate in large numbers from a lymphoid progenitor via an IL-7R+ Flt3+ precursor population containing cells with pDC or B cell potential. Technological advancements in recent years have allowed unprecedented resolution in the analysis of cell states, down to the single cell level, providing valuable information on the commitment and dynamics of differentiation of all DC subsets. However, the functional diversification of activated pDCs still raises the question whether different ontogenies generate restricted subsets, or fully differentiated cells still retain plasticity in response to challenges. The emergence of novel techniques for the integration of high-resolution data in individual cells promises interesting discoveries regarding DC development and plasticity in the near future.

Keywords: Plasmacytoid dendritic cells (pDC), Hematopoeisis, Dendritic cell development, Dendritic cell progenitors, plasticity, heterogeneity

Received: 04 Oct 2018; Accepted: 13 May 2019.

Edited by:

Christian Muenz, University of Zurich, Switzerland

Reviewed by:

Natalio Garbi, University of Bonn, Germany
Susan Kovats, Oklahoma Medical Research Foundation, United States
Diana Dudziak, Hautklinik, Universitätsklinikum Erlangen, Germany  

Copyright: © 2019 Musumeci, Lutz, Winheim and Krug. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Dr. Anne B. Krug, Ludwig Maximilian University of Munich, Institute for Immunology, Biomedical Center, Munich, 80802, Bavaria, Germany, anne.krug@med.uni-muenchen.de